University of Cambridge > > Lectures in Cancer Biology and Medicine > Artificial Intelligence for identifying novel therapeutic targets, biomarkers and drug repositioning opportunities

Artificial Intelligence for identifying novel therapeutic targets, biomarkers and drug repositioning opportunities

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Louisa Bellis.

These talks are aimed at Masters and first year PhD students but all are welcome to attend.

This talk will be given remotely on Google Meet

Abstract: The challenges in drug discovery, including high attrition rates in late development stage, are well documented. This has led to an increased interest and need for applying machine learning and artificial intelligence across the drug discovery pipeline from target identification to chemical lead selection and optimisation. It has also been demonstrated that drugs with human genetic validation data are more likely to succeed in the clinic. To address this, it is essential to unravel genetic networks to identify new or better targets for which the underlying mechanism is clear. Despite the significant advances in next generation sequencing technologies and evolving databases of patient cohorts, the sheer complexity of these datasets makes their integration and interrogation a daunting task. Through the development and application of cutting-edge computational approaches, such as artificial intelligence, machine learning and mathematical modelling, to pharmacogenomics and drug discovery, we identify novel therapeutic targets, biomarkers and drug repositioning opportunities. In this talk I will focus on (1) systematic integration and harmonisation of biomedical big data (2) multi-omic disease association study and (3) network theory-based analysis of targetable pathway which have significant potential to provide unprecedented insights into vital biological processes and the control hubs that underpin disease.

This talk is part of the Lectures in Cancer Biology and Medicine series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity